Skip to main content
. 2012 Jul 10;9(7):e1001245. doi: 10.1371/journal.pmed.1001245

Figure 2. Impact of treatment for a scenario with eligibility at CD4≤350 cells/µl, 80% access, and 85% retention.

Figure 2

(A) The percentage reduction in HIV incidence in the years 2020 and 2050 when eligibility for treatment is at CD4 count ≤350 cells/µl, 80% of individuals are treated, and 85% are retained on treatment after 3 y. (B) The cumulative number of person-years of ART provided per infection averted for the same scenario. Horizontal lines indicate 95% credible intervals (CI). For the Bendavid model, results in year 2040 are reported in the right panels.